Publication Cover
Endothelium
Journal of Endothelial Cell Research
Volume 15, 2008 - Issue 1-2
43
Views
8
CrossRef citations to date
0
Altmetric
Regular Articles

Antiapoptotic Activities of Bcl-2 Correlate with Vascular Maturation and Transcriptional Modulation of Human Endothelial Cells

, , , &
Pages 59-71 | Received 25 Oct 2008, Accepted 28 Mar 2008, Published online: 13 Jul 2009

REFERENCES

  • Affara M., Dunmore B. J., Savoie S., Imoto S., Tamada Y., Araki H., Charnock-Jones D. S., Miyano S., Print C. G. Understanding endothelial cell apoptosis: What can the transcriptome, glycome and proteome reveal?. Philosophical Transactions of the Royal Society B 2007; 362: 1469–1487
  • Baldi P., Long A. D. A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes. Bioinformatics 2001; 17: 509–519
  • Beissbarth T., Speed T. P. GOstat: Find statistically overrepresented gene ontologies within a group of genes. Bioinformatics 2004; 20: 1464–1465
  • Bellas R. E., Lee J. S., Sonenshein G. E. Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. Journal of Clinical Investigation 1995; 96: 2521–2527
  • Bostrom K., Tsao D., Shen S., Wang Y., Demer L. L. Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. Journal of Biological Chemistry 2001; 276: 14044–14052
  • Cheng E. H.-Y., Kirsch D. G., Clem R. J., Ravi R., Kastan M. B., Bedi A., Ueno K., Hardwick J. M. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 1997; 278: 1966–1968
  • Choi J., Choi K., Benveniste E. N., Hong Y.-S., Lee J.-H., Kim J., Park K. Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2. Cancer Res 2005; 65: 5554–5560
  • Cory S., Adams J. M. Killing cancer cells by flipping the Bcl-2/Bax switch. Cancer Cell 2005; 8: 5–6
  • de Moissac D., Mustapha S., Greenberg A. H., Kirshenbaum L. A. Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha. Journal of Biological Chemistry 1998; 273: 23946–23951
  • Duval H., Harris M., Li J., Johnson N., Print C. New insights into the function and regulation of endothelial cell apoptosis. Angiogenesis 2003; 6: 171–183
  • Duval H., Johnson N., Li J., Evans A., Chen S., Licence D., Skepper J., Charnock-Jones D. S., Smith S., Print C. Vascular development is disrupted by endothelial cell-specific expression of the anti-apoptotic protein Bcl-2. Angiogenesis 2007; 10: 55–68
  • Enis D. R., Shepherd B. R., Wang Y., Qasim A., Shanahan C. M., Weissberg P. L., Kashgarian M., Pober J. S., Schechner J. S. Induction, differentiation, and remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 2005; 102: 425–430
  • Filippov S., Koenig G. C., Chun T. H., Hotary K. B., Ota I., Bugge T. H., Roberts J. D., Fay W. P., Birkedal-Hansen H., Holmbeck K., et al. MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells. Journal of Experimental Medicine 2005; 202: 663–671
  • Gimbrone M. A., Jr. Culture of vascular endothelium. Progress in Hemostasis and Thrombosis 1976; 3: 1–28
  • Gross A., McDonnell J. M., Korsmeyer S. J. BCL-2 family members and the mitochondria in apoptosis. Genes and Development 1999; 13: 1899–1911
  • Hsieh T., Gordon R. E., Clemmons D. R., Busby W. H., Jr., Duan C. Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins. Journal of Biological Chemistry 2003; 278: 42886–42892
  • Iervolino A., Trisciuoglio D., Ribatti D., Candiloro A., Biroccio A., Zupi G., Del Bufalo D. Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity. FASEB Journal 2002; 16: 1453–1455
  • Ilan N., Mahooti S., Madri J. A. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. Journal of Cell Science 1998; 111: 3621–3631
  • Johnson N. A., Sengupta S., Saidi S. A., Lessan K., Charnock-Jones S. D., Scott L., Stephens R., Freeman T. C., Tom B. D., Harris M., et al. Endothelial cells preparing to die by apoptosis initiate a program of transcriptome and glycome regulation. FASEB Journal 2004; 18: 188–190
  • Kahn J., Mehraban F., Ingle G., Xin X., Bryant J. E., Vehar G., Schoenfeld J., Grimaldi C. J., Peale F., Draksharapu A., et al. Gene expression profiling in an in vitro model of angiogenesis. American Journal of Pathology 2000; 156: 1887–1900
  • Karl E., Warner K., Zeitlin B., Kaneko T., Wurtzel L., Jin T., Chang J., Wang S., Wang C. Y., Strieter R. M., et al. Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-kappaB and CXC chemokines. Cancer Research 2005; 65: 5063–5069
  • Kuwana T., Mackey M. R., Perkins G., Ellisman M. H., Latterich M., Schneiter R., Green D. R., Newmeyer D. D. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 2002; 111: 331–342
  • Li C., Wong W. H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proceedings of the National Academy of Sciences of the United States of America 2001; 98: 31–36
  • Linette G. P., Li Y., Roth K., Korsmeyer S. J. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proceedings of the National Academy of Sciences of the United States of America 1996; 93: 9545–9552
  • Lum J. J., DeBerardinis R. J., Thompson C. B. Autophagy in metazoans: Cell survival in the land of plenty. Nature Reviews in Molecular and Cellular Biology 2005; 6: 439–448
  • Madge L. A., Sierra-Honigmann M. R., Pober J. S. Apoptosis-inducing agents cause rapid shedding of tumor necrosis factor receptor 1 (TNFR1). A nonpharmacological explanation for inhibition of TNF-mediated activation. Journal of Biological Chemistry 1999; 274: 13643–13549
  • Massaad C. A., Portier B. P., Taglialatela G. Inhibition of transcription factor activity by nuclear compartment-associated Bcl-2. Journal of Biological Chemistry 1999; 279: 54470–54478
  • Nor J. E., Christensen J., Mooney D. J., Polverini P. J. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. American Journal of Pathology 1999; 154: 375–384
  • Ohtsu H., Dempsey P. J., Frank G. D., Brailoiu E., Higuchi S., Suzuki H., Nakashima H., Eguchi K., Eguchi S. ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II. Arteriosclerosis, Thrombosis, and Vascular Biology 2006; 26: e133–e137
  • Proudfoot D., Shanahan C. M. Molecular mechanisms mediating vascular calcification: Role of matrix Gla protein. Nephrology (Carlton) 2006; 11: 455–461
  • Rivard A., Principle N., Andres V. Age-dependent increase in c-fos activity and cyclin A expression in vascular smooth muscle cells. A potential link between aging, smooth muscle cell proliferation and atherosclerosis. Cardiovascular Research 2000; 54: 1026–1034
  • Rosenkilde M. M., Schwartz T. W. The chemokine system—a major regulator of angiogenesis in health and disease. APMIS 2004; 112: 481–495
  • Saidi S. A., Holland C. M., Kreil D. P., MacKay D. J., Charnock-Jones D. S., Print C. G., Smith S. K. Independent component analysis of microarray data in the study of endometrial cancer. Oncogene 2004; 23: 6677–6683
  • Schechner J. S., Nath A. K., Zheng L., Kluger M. S., Hughes C. C., Sierra-Honigmann M. R., Lorber M. I., Tellides G., Kashgarian M., Bothwell A. L., et al. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proceedings of the National Academy of Sciences of the United States of America 2000; 97: 9191–9196
  • Strasser A. The role of BH3-only proteins in the immune system. Nature Reviews in Immunology 2005; 5: 189–200
  • Thornton S. C., Mueller S. N., Levine E. M. Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science 1983; 222: 623–625
  • Vadigepalli R., Chakravarthula P., Zak D. E., Schwaber J. S., Gonye G. E. PAINT: A promoter analysis and interaction network generation tool for gene regulatory network identification. OMICS 2003; 7: 235–252
  • Vailhe B., Vittet D., Feige J. J. In vitro models of vasculogenesis and angiogenesis. Laboratory Investigation 2001; 81: 439–452
  • Vaux D. L., Cory S., Adams J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440–442
  • Yana I., Sagara H., Takaki S., Takatsu K., Nakamura K., Nakao K., Katsuki M., Taniguchi S., Aoki T., Sato H., et al. Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells. Journal of Cell Science 2007; 120: 1607–1614
  • Yin X. M., Oltvai Z. N., Korsmeyer S. J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 1994; 369: 321–323
  • Zuckerbraun B. S., McCloskey C. A., Mahidhara R. S., Kim P. K., Taylor B. S., Tzeng E. Overexpression of mutated IkappaBalpha inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation. Journal of Vascular Surgery 2003; 38: 812–819
  • Zhang F., Hackett N. R., Lam G., Cheng J., Pergolizzi R., Luo L., Shmelkov S. V., Edelberg J., Crystal R. G., Rafii S. Green fluorescent protein selectively induces HSP70-mediated up-regulation of COX-2 expression in endothelial cells. Blood 2003; 102: 2115–2121
  • Zheng L., Ben L. H., Pober J. S., Bothwell A. L. Porcine endothelial cells, unlike human endothelial cells, can be killed by human CTL via Fas ligand and cannot be protected by Bcl-2. Journal of Immunology 2002; 169: 6850–6855
  • Zheng L., Dengler T. J., Kluger M. S., Madge L. A., Schechner J. S., Maher S. E., Pober J. S., Bothwell A. L. Cytoprotection of human umbilical vein endothelial cells against apoptosis and CTL-mediated lysis provided by caspase-resistant Bcl-2 without alterations in growth or activation responses. Journal of Immunology 2000; 164: 4665–4671
  • Zheng L., Gibson T. F., Schechner J. S., Pober J. S., Bothwell A. L. Bcl-2 transduction protects human endothelial cell synthetic microvessel grafts from allogeneic T cells in vivo. Journal of Immunology 2004; 173: 3020–3026
  • Zhou J., Callapina M., Goodall G. J., Brune B. Functional integrity of nuclear factor κ B, phosphatidylinositol 3′-kinase, and mitogen-activated protein kinase signaling allows tumor necrosis factor α -evoked Bcl-2 expression to provoke internal ribosome entry site-dependent translation of hypoxia-inducible factor 1alpha. Cancer Research 2004; 64: 9041–9048

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.